Calamos Advisors’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $217M | Buy |
|
|||||
|
2025
Q1 | $226M | Sell |
|
|||||
|
2024
Q4 | $225M | Buy |
|
|||||
|
2024
Q3 | $256M | Sell |
|
|||||
|
2024
Q2 | $300M | Sell |
|
|||||
|
2024
Q1 | $263M | Sell |
|
|||||
|
2023
Q4 | $218M | Sell |
|
|||||
|
2023
Q3 | $202M | Sell |
|
|||||
|
2023
Q2 | $181M | Sell |
|
|||||
|
2023
Q1 | $143M | Sell |
|
|||||
|
2022
Q4 | $164M | Sell |
|
|||||
|
2022
Q3 | $163M | Buy |
|
|||||
|
2022
Q2 | $161M | Sell |
|
|||||
|
2022
Q1 | $143M | Buy |
|
|||||
|
2021
Q4 | $134M | Buy |
|
|||||
|
2021
Q3 | $106M | Sell |
|
|||||
|
2021
Q2 | $107M | Buy |
|
|||||
|
2021
Q1 | $74.5M | Buy |
|
|||||
|
2020
Q4 | $57.8M | Sell |
|
|||||
|
2020
Q3 | $53.3M | Buy |
|
|||||
|
2020
Q2 | $56.1M | Buy |
|
|||||
|
2020
Q1 | $35.2M | Sell |
|
|||||
|
2019
Q4 | $34.9M | Sell |
|
|||||
|
2019
Q3 | $30M | Sell |
|
|||||
|
2019
Q2 | $31.2M | Buy |
|
|||||
|
2019
Q1 | $35.8M | Buy |
|
|||||
|
2018
Q4 | $31.9M | Buy |
|
|||||
|
2018
Q3 | $27.4M | Buy |
|
|||||
|
2018
Q2 | $21.2M | Buy |
|
|||||
|
2018
Q1 | $18.2M | Buy |
|
|||||
|
2017
Q4 | $19.5M | Sell |
|
|||||
|
2017
Q3 | $34.1M | Buy |
|
|||||
|
2017
Q2 | $32.6M | Buy |
|
|||||
|
2017
Q1 | $32.7M | Sell |
|
|||||
|
2016
Q4 | $28.6M | Sell |
|
|||||
|
2016
Q3 | $34.7M | Buy |
|
|||||
|
2016
Q2 | $34.1M | Buy |
|
|||||
|
2016
Q1 | $31.2M | Buy |
|
|||||
|
2015
Q4 | $35.9M | Hold |
|
|||||
|
2015
Q3 | $35.7M | Buy |
|
|||||
|
2015
Q2 | $35.6M | Sell |
|
|||||
|
2015
Q1 | $32M | Buy |
|
|||||
|
2014
Q4 | $29.8M | Buy |
|
|||||
|
2014
Q3 | $28M | Hold |
|
|||||
|
2014
Q2 | $26.8M | Buy |
|
|||||
|
2014
Q1 | $25M | Hold |
|
|||||
|
2013
Q4 | $21.6M | Hold |
|
|||||
|
2013
Q3 | $21.4M | Buy |
|
|||||
|
2013
Q2 | $16.4M | Buy |
|